Cargando…

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial

BACKGROUND: The addition of a GnRH analogue to the luteal phase in in vitro fertilization programs has been seldom proposed due to the presence of GnRH receptors in the endometrium. The aim of the study was to evaluate the effect of triptorelin addition in short antagonist cycles, compared to cycles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fusi, Francesco M., Brigante, Claudio M., Zanga, Laura, Mignini Renzini, Mario, Bosisio, Chiara, Fadini, Rubens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884808/ https://www.ncbi.nlm.nih.gov/pubmed/31783862 http://dx.doi.org/10.1186/s12958-019-0543-2

Ejemplares similares

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders
por: Fàbregues, Francesc, et al.
Publicado: (2019)

Oxidative Stress Markers in GnRH Agonist and Antagonist Protocols in IVF
por: Tulić, Lidija, et al.
Publicado: (2017)

GnRH Antagonist IVF Protocol in PCOS
por: Onofriescu, Alina, et al.
Publicado: (2013)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
por: Alyasin, Ashraf, et al.
Publicado: (2016)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study
por: Kaur, Harpreet, et al.
Publicado: (2012)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
por: Turgay Çelik, Gayem İnayet, et al.
Publicado: (2015)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
por: Youssef, M.A.F., et al.
Publicado: (2015)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
por: Benmachiche, Abdelhamid, et al.
Publicado: (2017)

Estradiol use in the luteal phase and its effects on pregnancy rates in IVF cycles with GnRH antagonist: a systematic review
por: Pinheiro, Lanna Marla Andrade, et al.
Publicado: (2017)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013)

Luteal blood flow in patients undergoing GnRH agonist long protocol
por: Takasaki, Akihisa, et al.
Publicado: (2011)

Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis
por: Xiao, Jin-song, et al.
Publicado: (2014)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial
por: Salehpour, Saghar, et al.
Publicado: (2021)

Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
por: Zhu, Shaomi, et al.
Publicado: (2022)

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization
por: Jing, Miaomiao, et al.
Publicado: (2020)

A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
por: Gordts, S., et al.
Publicado: (2012)

Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis
por: Kadoura, Sally, et al.
Publicado: (2022)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
por: Yang, Wen-Jui, et al.
Publicado: (2009)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation
por: Orvieto, Raoul
Publicado: (2015)

Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis
por: Oliveira, João Batista A, et al.
Publicado: (2010)

A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience
por: Kaur, Harpreet, et al.
Publicado: (2012)

GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles
por: de Oliveira Filho, Condesmar M., et al.
Publicado: (2021)

The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
por: Seyhan, Ayse, et al.
Publicado: (2011)

Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles
por: Choi, Min Hye, et al.
Publicado: (2012)

GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
por: Sperduti, Samantha, et al.
Publicado: (2019)

Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial
por: Zhang, Yisheng, et al.
Publicado: (2021)

Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study
por: Gui, Juan, et al.
Publicado: (2022)

Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
por: Devjak, Rok, et al.
Publicado: (2012)

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(−/−) mice
por: Knutsson, Anki, et al.
Publicado: (2016)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
por: Zhao, Depeng, et al.
Publicado: (2023)

A propensity score matching comparison between GnRH agonist and GnRH antagonist protocols in patients in POSEIDON groups 3 and 4
por: Tan, Jifan, et al.
Publicado: (2023)

Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review
por: Kuan, Kevin K.W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7isjpp0rb1c24bqhn5sgevoliu